Matthew Lindon
Plus aucun poste en cours
Profil
Matthew Lindon worked as a Global Project Leader at AstraZeneca AB.
He also worked as the Chief Scientific Officer at LIDDS AB for a year in 2023.
Prior to his professional experience, he completed his undergraduate degree at the University of Leicester.
Anciens postes connus de Matthew Lindon
| Sociétés | Poste | Fin |
|---|---|---|
| LIDDS AB | Directeur Général | 01/12/2023 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Formation de Matthew Lindon
| University of Leicester | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LIDDS AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
